Missed rifampicin and isoniazid resistance by commercial molecular assays
Drug-resistant tuberculosis (TB) has poor outcomes unless resistance is detected early, ideally by commercially available molecular tests. We present a case of occult multidrug-resistant TB where both rifampicin and isoniazid resistance were missed by molecular testing and were only identified...
Saved in:
Main Authors: | L Richards, F Ismail, J Nel, S V Omar |
---|---|
Format: | Article |
Language: | English |
Published: |
South African Medical Association
2024-07-01
|
Series: | South African Medical Journal |
Subjects: | |
Online Access: | https://samajournals.co.za/index.php/samj/article/view/1779 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of Rifampicin Resistance in Presumptive Tuberculosis Cases at Dadeldhura Hospital of Sudurpaschim Province of Nepal
by: Madan Singh Bohara
Published: (2025-02-01) -
Time to be seen and heard: Including children’s and adolescents’ voices in the South African TB response
by: C Goslett, et al.
Published: (2024-07-01) -
Analytical and clinical validation of a novel MeltPlus TB-NTM/RIF platform for simultaneous detection of Mycobacterium tuberculosis complex, Non-Tuberculous Mycobacteria and rifampicin resistance
by: Zhuo Wang, et al.
Published: (2025-02-01) -
Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa
by: J-D K Lotz, et al.
Published: (2023-11-01) -
Factors that shape the integration of HIV and TB services in Zomba District, Malawi
by: Alex F. Maseko, et al.
Published: (2025-02-01)